(Q34929064)

5 August 2017

1 reference

title

Chromosomal and genetic abnormalities in myeloma (English)

1 reference

5 August 2017

Joy Ho P

1

1 reference

5 August 2017

publication date

1 October 2002

1 reference

International Journal of Laboratory Hematology

5 August 2017

published in

1 reference

5 August 2017

volume

24

1 reference

5 August 2017

issue

5

1 reference

5 August 2017

page(s)

259-269

1 reference

Evidence that the clonogenic cell in multiple myeloma originates from a pre-switched but somatically mutated B cell.

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2002.00456.X

Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2002.00456.X

Chromosome translocations in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2002.00456.X

Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2002.00456.X

Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2002.00456.X

Evidence for a bone marrow B cell transcribing malignant plasma cell VDJ joined to C mu sequence in immunoglobulin (IgG)- and IgA-secreting multiple myelomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2002.00456.X

Association of SET domain and myotubularin-related proteins modulates growth control

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2002.00456.X

Multiple myeloma and the translocation t(11;14)(q13;q32): a report on 13 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2002.00456.X

IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2002.00456.X

Illegitimate switch recombinations are present in approximately half of primary myeloma tumors, but do not relate to known prognostic indicators or survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2002.00456.X

Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2002.00456.X

Analysis of FGFR3 gene mutations in multiple myeloma patients with t(4;14)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2002.00456.X

Signal transduction pathway of human fibroblast growth factor receptor 3. Identification of a novel 66-kDa phosphoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2002.00456.X

Predictive role of interphase cytogenetics for survival of patients with multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2002.00456.X

The myeloma-associated oncogene fibroblast growth factor receptor 3 is transforming in hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2002.00456.X

Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2002.00456.X

Ras oncogene mutation in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2002.00456.X

Genomic organization of the human fibroblast growth factor receptor 3 (FGFR3) gene and comparative sequence analysis with the mouse Fgfr3 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2002.00456.X

Immunohistochemical analysis of cyclin D1 shows deregulated expression in multiple myeloma with the t(11;14).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2002.00456.X

Cyclin D3 at 6p21 is dysregulated by recurrent chromosomal translocations to immunoglobulin loci in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2002.00456.X

Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2002.00456.X

WHSC1, a 90 kb SET domain-containing gene, expressed in early development and homologous to a Drosophila dysmorphy gene maps in the Wolf-Hirschhorn syndrome critical region and is fused to IgH in t(4;14) multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2002.00456.X

Non-random chromosomal rearrangements and their implications in clinical features and outcome of multiple myeloma and plasma cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2002.00456.X

Profound ligand-independent kinase activation of fibroblast growth factor receptor 3 by the activation loop mutation responsible for a lethal skeletal dysplasia, thanatophoric dysplasia type II

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2002.00456.X

Detection of MUM1/IRF4-IgH fusion in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2002.00456.X

The retinoblastoma gene (RB-1) status in multiple myeloma: a report on 35 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2002.00456.X

Persistent preswitch clonotypic myeloma cells correlate with decreased survival: evidence for isotype switching within the myeloma clone

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2002.00456.X

The t(4;14)(p16.3;q32) is strongly associated with chromosome 13 abnormalities in both multiple myeloma and monoclonal gammopathy of undetermined significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2002.00456.X

The (11;14)(q13;q32) Translocation in Multiple Myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2002.00456.X

Prognostic value of cytogenetics in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2002.00456.X

Cytogenetic, interphase, and multicolor fluorescence in situ hybridization analyses in primary plasma cell leukemia: a study of 40 patients at diagnosis, on behalf of the Intergroupe Francophone du Myélome and the Groupe Français de Cytogénétique Hé

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2002.00456.X

Chromosome 13 abnormalities in multiple myeloma are mostly monosomy 13

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2002.00456.X

Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2002.00456.X

Chromosome 13 abnormalities identified by FISH analysis and serum beta2-microglobulin produce a powerful myeloma staging system for patients receiving high-dose therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2002.00456.X

Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2002.00456.X

Rare occurrence of P53 gene mutations in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2002.00456.X

Multicolour spectral karyotyping identifies new translocations and a recurring pathway for chromosome loss in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2002.00456.X

Cytogenetic findings in 200 patients with multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2002.00456.X

10.1046/J.1365-2257.2002.00456.X

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference